The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Turmeric: The Evidence for Therapeutic Use for Arthritis

Turmeric: The Evidence for Therapeutic Use for Arthritis

November 19, 2018 • By Samantha C. Shapiro, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A 2018 systematic review and meta-analysis in the British Journal of Sports Medicine included 69 randomized controlled trials that examined the use of a variety of dietary supplements in patients with knee, hip and hand osteoarthritis.4 Only three of these trials evaluated turmeric specifically. Only 10% of studies were judged at “low risk of bias,” and 64% were funded by pharmaceutical companies. That said, turmeric had a moderate effect on short-term-pain- and physical function-based visual analogue scales, with standard mean deviations of -1.19 and -1.13, respectively. In comparison, studies of glucosamine and chondroitin—supplements widely used by many osteoarthritis patients today—showed no benefit over placebo.

You Might Also Like
  • More Evidence Dexamethasone Speeds Recovery in Kids with Septic Arthritis
  • Study Examines Why Patients Exceed Recommended Doses of Ibuprofen & NSAIDs
  • Opening a New Therapeutic Window for Rheumatoid Arthritis
Explore This Issue
November 2018
Also By This Author
  • A Young Disease: A Holistic Approach to the Treatment of Antiphospholipid Syndrome

Safety Profile

As studied to date, turmeric is generally safe to ingest. At extremely high doses (upward of 8,000 mg daily), patients may experience gastrointestinal upset or bleeding, especially if on concomitant anticoagulation. Doses used in arthritis have typically not exceeded 2,000 mg daily, and this dose has not caused significant adverse effects.5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Some debate exists as to the bioavailability of curcumin; ingesting curcumin as a cooked ingredient in hot food, with a fatty meal or with black pepper (piperine) may enhance absorption.

The Bottom Line

So what do I tell my patients when they ask? I tell them studies have demonstrated anti-inflammatory and anti-oxidative properties of turmeric. We need more data to determine if it is truly effective for joint pain, but it is generally safe and may be worth trying as an adjunctive therapy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I recommend a total daily dose of 1,000 to 2,000 mg of curcumin, which is equivalent to about five to 10 teaspoons of turmeric spice. I encourage patients to read package labels if they are purchasing curcumin supplements to confirm that no extraneous ingredients have been added.

When possible, they should look for a seal from U.S. Pharmacopeia (USP), NSF International, ConsumerLab.com or UL. For a fee paid by the supplement manufacturing company, these organizations work to certify that supplements contain the amount of product advertised and are not contaminated with toxic substances (e.g., arsenic, lead).

Moving forward, larger clinical trials are needed to determine if turmeric is truly effective for the treatment of arthritis. It may be worthwhile to examine turmeric in combination with other interventions, as well as the effect of different doses and bioformulations of curcumin.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In a digital era where false information abounds, a few minutes to discuss the benefits (if any) and risks of supplements with our patients can be of paramount importance to their health and well-being.


Samantha C. Shapiro, MDSamantha C. Shapiro, MD, completed residency and fellowship training at the Johns Hopkins University School of Medicine in Baltimore. She is now an assistant professor of medicine at  Dell Medical School at the University of Texas at Austin, where she is serving as the inaugural rheumatologist at the school.

 

References

  1. Peddada KV, Peddada KV, Shukla SK, et al. Role of curcumin in common musculoskeletal disorders: A review of current laboratory, translational, and clinical data. Orthop Surg. 2015 Aug;7(3):222–231. doi:10.1111/os.12183.
  2. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: A multicenter study. Clin Interv Aging. 2014 Mar 20;9:451–458. doi:10.2147/CIA.S58535.
  3. Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016 Aug;19(8):717–729. doi:10.1089/jmf.2016.3705.
  4. Liu X, Machado GC, Eyles JP, et al. Dietary supplements for treating osteoarthritis: A systematic review and meta-analysis. Br J Sports Med. 2018 Feb;52(3):167–175. doi:10.1136/bjsports-2016-097333.
  5. Turmeric. National Center for Complementary and Integrative Health. Updated Sep 2016.

Pages: 1 2 3 | Single Page

Filed Under: Drug Updates, Safety Tagged With: TurmericIssue: November 2018

You Might Also Like:
  • More Evidence Dexamethasone Speeds Recovery in Kids with Septic Arthritis
  • Study Examines Why Patients Exceed Recommended Doses of Ibuprofen & NSAIDs
  • Opening a New Therapeutic Window for Rheumatoid Arthritis
  • Glucosamine Supplements Don’t Help Knee or Hip Arthritis Pain

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)